@article{5c0ac660afe243fb9478ec9d167a15ed,
title = "Real-world experiences with intravitreal treatment with ranibizumab and aflibercept for diabetic macular oedema 2008-2021",
keywords = "Aged, Angiogenesis Inhibitors/administration \& dosage, Diabetic Retinopathy/drug therapy, Female, Humans, Intravitreal Injections, Macular Edema/drug therapy, Male, Middle Aged, Ranibizumab/administration \& dosage, Receptors, Vascular Endothelial Growth Factor/administration \& dosage, Recombinant Fusion Proteins/administration \& dosage, Retrospective Studies, Tomography, Optical Coherence/methods, Treatment Outcome, Vascular Endothelial Growth Factor A/antagonists \& inhibitors, Visual Acuity",
author = "Lindboe, \{Johanne Bjerre\} and Troels Brynskov and S{\o}rensen, \{Torben Lykke\} and \{Schmidt Laugesen\}, Caroline",
year = "2024",
month = jun,
doi = "10.1111/aos.16677",
language = "English",
volume = "102",
pages = "e661--e662",
journal = "Acta Ophthalmologica",
issn = "1755-375X",
publisher = "John Wiley \& Sons Inc.",
number = "4",
}